B
ICCC icon

Bailard’s ImmuCell ICCC Stock Holding History

Bailard’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.9K Buy
+10,102
New +$64.7K ﹤0.01% 734

Other funds holding ICCC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return

Bailard's ICCC Position: Q1 2026 in Review

Bailard opened a new position in ImmuCell (ICCC) in Q1 2026: 10,102 shares worth $63.9K. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings.

27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Bailard held 10,102 shares of ImmuCell worth $63.9K as of Q1 2026.
  • ImmuCell was a new Bailard position in Q1 2026.
  • ImmuCell made up ﹤0.01% of Bailard's portfolio in Q1 2026, its #734 holding.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.